NewCardio Gross Margin 2010-2011 | NWCI
Current and historical gross margin for NewCardio (NWCI) over the last 10 years. The current gross profit margin for NewCardio as of September 30, 2011 is %.
| NewCardio Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2011-09-30 | $0.00B | 0 | 0.00% |
| 2011-06-30 | $0.00B | 0 | 0.00% |
| 2011-03-31 | $0.00B | 0 | 0.00% |
| 2010-12-31 | $0.00B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.000B | $0.000B |
| NewCardio, Inc. (NewCardio), through its wholly owned subsidiary, NewCardio Technologies, Inc. (NewCardio Technologies). The Company is focused on the development of a platform technology for its products, which will improve the diagnostic accuracy and value of the standard 12-lead electrocardiogram (ECG). The Company has used its core technology platform to develop three initial products: QTinno, Cardio3KG and CardioBip, which are in various stages of development. QTinno is an automated cardiac safety solution that streamlines the process for meeting the Phase I cardiac safety analysis requirements. The prototype of CardioBip is a mobile ECG transtelephonic system consisting of a mobile ECG recording and transmitting device, and a diagnostic center, which receives, processes and analyzes the data. Cardio3KG is a set of algorithms and tools that provide a method to assess cardiac electrical activity in time and space. | |||